Silk-Based Technique Stabilizes Fluid Samples for Diagnostics or Research
By LabMedica International staff writers Posted on 01 Jun 2016 |
Image: Cocoons of the silk moth Bombyx mori were used to isolate the silk fibroin used in the study (Photo courtesy of Wikimedia Commons).
Drying blood or other biological fluid samples together with silk fibroin has been suggested as an alternative to refrigeration or drying on paper for transporting specimens from the field to the laboratory.
Without proper temperature regulation, protein biomarkers in particular can degrade rapidly in blood samples, an effect that ultimately compromises the quality and reliability of laboratory tests. Existing alternative collection and storage solutions, such as drying blood on paper cards, still fail to effectively protect biomarkers from heat and humidity.
Investigators at Tufts University (Medford, MA, USA) have described an alternative silk matrix encapsulation technique that overcomes these limitations and can be deployed using a simple air-drying approach. They mixed a solution or a powder of purified silk fibroin protein extracted from silkworm cocoons with blood or plasma and air-dried the mixture. The air-dried silk films were stored for up to 84 days at temperatures between 22 and 45 degrees Celsius. At set intervals, encapsulated blood samples were recovered by dissolving the films in water and analyzed.
Results revealed that the silk-based technique required accurate starting volumes of the blood or other specimens to be analyzed. Salts or other buffers were needed in some cases to reconstitute samples for accurate testing of certain markers. When these conditions were met, the investigators found that the silk fiber drying process was compatible with a number of immunoassays and provided enhanced sample preservation in comparison with traditional air-drying paper approaches.
"This approach should facilitate outpatient blood collection for disease screening and monitoring, particularly for underserved populations, and also serve needs of researchers and clinicians without access to centralized testing facilities. For example, this could support large-scale epidemiologic studies or remote pharmacological trials," said senior author Dr. David L. Kaplan, professor of biomedical engineering at Tufts University.
The process was described in detail in the May 9, 2016, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences.
Related Links:
Tufts University
Without proper temperature regulation, protein biomarkers in particular can degrade rapidly in blood samples, an effect that ultimately compromises the quality and reliability of laboratory tests. Existing alternative collection and storage solutions, such as drying blood on paper cards, still fail to effectively protect biomarkers from heat and humidity.
Investigators at Tufts University (Medford, MA, USA) have described an alternative silk matrix encapsulation technique that overcomes these limitations and can be deployed using a simple air-drying approach. They mixed a solution or a powder of purified silk fibroin protein extracted from silkworm cocoons with blood or plasma and air-dried the mixture. The air-dried silk films were stored for up to 84 days at temperatures between 22 and 45 degrees Celsius. At set intervals, encapsulated blood samples were recovered by dissolving the films in water and analyzed.
Results revealed that the silk-based technique required accurate starting volumes of the blood or other specimens to be analyzed. Salts or other buffers were needed in some cases to reconstitute samples for accurate testing of certain markers. When these conditions were met, the investigators found that the silk fiber drying process was compatible with a number of immunoassays and provided enhanced sample preservation in comparison with traditional air-drying paper approaches.
"This approach should facilitate outpatient blood collection for disease screening and monitoring, particularly for underserved populations, and also serve needs of researchers and clinicians without access to centralized testing facilities. For example, this could support large-scale epidemiologic studies or remote pharmacological trials," said senior author Dr. David L. Kaplan, professor of biomedical engineering at Tufts University.
The process was described in detail in the May 9, 2016, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences.
Related Links:
Tufts University
Latest Technology News
- New Diagnostic System Achieves PCR Testing Accuracy
- DNA Biosensor Enables Early Diagnosis of Cervical Cancer
- Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
- Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
- First of Its Kind Technology Detects Glucose in Human Saliva
- Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop
- Novel Noninvasive Test Detects Malaria Infection without Blood Sample
- Portable Optofluidic Sensing Devices Could Simultaneously Perform Variety of Medical Tests
- Point-of-Care Software Solution Helps Manage Disparate POCT Scenarios across Patient Testing Locations
- Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents
- Breakthrough Test Detects Biological Markers Related to Wider Variety of Cancers
- Rapid POC Sensing Kit to Determine Gut Health from Blood Serum and Stool Samples
- Device Converts Smartphone into Fluorescence Microscope for Just USD 50
- Wi-Fi Enabled Handheld Tube Reader Designed for Easy Portability